Keyphrases
Working Diagnosis
100%
Survival Rate
100%
Event-free Survival
100%
Group Studies
100%
Pediatric Oncology
100%
Ifosfamide
100%
Metastatic Osteosarcoma
100%
Nodule
75%
Confidence Interval
50%
Lung Metastasis
50%
Multi-agent
50%
Osteosarcoma
25%
Doxorubicin
25%
Bone Metastasis
25%
Hypokalemia
25%
Chemotherapeutic Regimens
25%
High-dose Methotrexate (HD-MTX)
25%
Lymph Node Metastasis
25%
Postsurgical
25%
Hematopoietic Toxicity
25%
Metastatic Site
25%
Primary Tumor Site
25%
Unilateral Involvement
25%
Hypophosphatemia
25%
Renal Toxicity
25%
Low-dose Cisplatin
25%
S-Rate
25%
Nursing and Health Professions
Osteosarcoma
100%
Survival Rate
100%
Event Free Survival
100%
Childhood Cancer
100%
Ifosfamide
100%
Confidence Interval
50%
Lung Metastasis
50%
Primary Tumor
25%
Nephrotoxicity
25%
Cisplatin
25%
Methotrexate
25%
Drug Megadose
25%
Bone Metastasis
25%
Doxil
25%
Lymph Node Metastasis
25%
Hypokalemia
25%
Hypophosphatemia
25%
Medicine and Dentistry
Osteosarcoma
100%
Childhood Cancer
100%
Survival Rate
100%
Event Free Survival
100%
Ifosfamide
100%
Lung Metastasis
50%
Drug Megadose
25%
Primary Tumor
25%
Nephrotoxicity
25%
Cisplatin
25%
Doxorubicin
25%
Bone Metastasis
25%
Methotrexate
25%
Lymph Node Metastasis
25%
Hypokalemia
25%
Hypophosphatemia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Survival Rate
100%
Osteosarcoma
100%
Event Free Survival
100%
Childhood Cancer
100%
Ifosfamide
100%
Lung Metastasis
50%
Nephrotoxicity
25%
Cisplatin
25%
Doxorubicin
25%
Primary Tumor
25%
Hypokalemia
25%
Methotrexate
25%
Bone Metastasis
25%
Lymph Node Metastasis
25%
Hypophosphatemia
25%
Biochemistry, Genetics and Molecular Biology
Survival Rate
100%
Event Free Survival
100%
Ifosfamide
100%
Doxorubicin
25%
Cisplatin
25%
Drug Megadose
25%
Hypophosphatemia
25%
Hypokalemia
25%
Methotrexate
25%